Roche Holding AG (OTCMKTS:RHHBY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

by · The Markets Daily

Roche Holding AG (OTCMKTS:RHHBY – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and three have given a strong buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $57.00.

Several brokerages have recently weighed in on RHHBY. HSBC reaffirmed a “buy” rating and set a $57.00 target price on shares of Roche in a research note on Wednesday, December 10th. Morgan Stanley restated an “underweight” rating on shares of Roche in a research report on Tuesday, December 2nd. Barclays upgraded shares of Roche from an “equal weight” rating to an “overweight” rating in a research report on Tuesday, January 6th. Hsbc Global Res upgraded shares of Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 2nd. Finally, Zacks Research upgraded Roche from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th.

Check Out Our Latest Stock Analysis on RHHBY

Roche Stock Performance

OTCMKTS RHHBY opened at $54.25 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.29 and a debt-to-equity ratio of 0.80. Roche has a twelve month low of $34.75 and a twelve month high of $54.53. The stock has a 50-day moving average of $49.97 and a 200 day moving average of $44.35.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in RHHBY. Curio Wealth LLC acquired a new stake in Roche during the 3rd quarter worth $25,000. Oakworth Capital Inc. acquired a new stake in shares of Roche in the third quarter valued at about $57,000. First Horizon Advisors Inc. lifted its stake in shares of Roche by 81.2% in the second quarter. First Horizon Advisors Inc. now owns 1,843 shares of the company’s stock worth $75,000 after buying an additional 826 shares in the last quarter. Salomon & Ludwin LLC lifted its stake in shares of Roche by 256.6% in the third quarter. Salomon & Ludwin LLC now owns 2,853 shares of the company’s stock worth $129,000 after buying an additional 2,053 shares in the last quarter. Finally, Albert D Mason Inc. acquired a new position in Roche during the fourth quarter worth about $207,000.

About Roche

(Get Free Report)

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.

See Also